Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03785834 · ClinicalTrials.gov registry record
The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 56
- Enrollment target
NCT03785834 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 56 participants.
The verdict
NCT03785834 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The Investigators wish to study the value of dermatologic testing assessments in differentiating between cellulitis and pseudocellulitis in the inpatient setting. The Investigators propose that by utilizing cutaneous biopsies and tissue cultures in patients that have been admitted to inpatient internal medicine teams, the investigators may be able to improve multiple measures of hospital efficiency in patients presenting with cellulitis-like symptoms, by more accurately recognizing cellulitis from pseudocellulitis. The patient will undergo encrypted digital imaging for his or her condition. This image will then be sent to the study investigators, along with basic clinical information on the skin evaluation form. The study investigators will develop a differential diagnosis and then the patient will undergo a skin biopsy. The patient will then be randomized to one of two arms using a random number generator: A) Skin biopsies and tissue cultures recorded and published in patient's medical chart as they would be in a standard of care procedure B) Skin biopsies and tissue cultures consultation performed but not published in the patient's medical chart unless medically necessary. Information will be collected from medical records in IHIS. Patients will be contacted by phone 30 days after discharge.
Interventions
- PROCEDURE Punch Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-05-25 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03785834
The ClinicalTrials.gov registry entry for NCT03785834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Punch Biopsy is the first listed.
NCT03785834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03785834 about?
NCT03785834 is a clinical study titled "The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis". The Investigators wish to study the value of dermatologic testing assessments in differentiating between cellulitis and pseudocellulitis in the inpatient setting. The Investigators propose that by utilizing cutaneous biopsies and tissue cultures in patients that have been admitted to inpatient inter...
What is the current status of trial NCT03785834?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2018-05-25. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT03785834?
The interventions under investigation include: Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03785834?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.